Trandolapril (BioDeep_00000016625)

   


代谢物信息卡片


Trandolapril

化学式: C24H34N2O5 (430.24675940000003)
中文名称: 群多普利, 苯那非普利特甲基酯
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
InChI: InChI=1S/C24H34N2O5/c1-3-31-24(30)19(14-13-17-9-5-4-6-10-17)25-16(2)22(27)26-20-12-8-7-11-18(20)15-21(26)23(28)29/h4-6,9-10,16,18-21,25H,3,7-8,11-15H2,1-2H3,(H,28,29)/t16-,18+,19-,20-,21-/m0/s1

描述信息

C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

同义名列表

1 个代谢物同义名

Trandolapril



数据库引用编号

9 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Emrah Gün, Mahmut Çiçek, Mustafa Kafalı, Hüsnü Demir, İlknur Arslan, Tanıl Kendirli. Use of Intravenous Lipid Emulsion Therapy and Insulin in a Case of Tarka Intoxication. WMJ : official publication of the State Medical Society of Wisconsin. 2024 May; 123(2):144-146. doi: ". [PMID: 38718248]
  • Majid Jaberi-Douraki, Emma Meyer, Jim Riviere, Nuwan Indika Millagaha Gedara, Jessica Kawakami, Gerald J Wyckoff, Xuan Xu. Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity. Scientific reports. 2021 06; 11(1):13349. doi: 10.1038/s41598-021-92734-7. [PMID: 34172790]
  • Laura Prieto-García, Laura Vicente-Vicente, Víctor Blanco-Gozalo, Omar Hidalgo-Thomas, María C García-Macías, Armin Kurtz, Anita T Layton, Ana B Sanz, Ana I Morales, Carlos Martínez-Salgado, Miguel Pericacho, Sandra M Sancho-Martínez, Francisco J López-Hernández. Pathophysiological mechanisms underlying a rat model of triple whammy acute kidney injury. Laboratory investigation; a journal of technical methods and pathology. 2020 11; 100(11):1455-1464. doi: 10.1038/s41374-020-0473-9. [PMID: 32719543]
  • Brian A Bergmark, Jacob A Udell, David A Morrow, Petr Jarolim, Julia F Kuder, Scott D Solomon, Marc A Pfeffer, Eugene Braunwald, Marc S Sabatine. Klotho, fibroblast growth factor-23, and the renin-angiotensin system - an analysis from the PEACE trial. European journal of heart failure. 2019 04; 21(4):462-470. doi: 10.1002/ejhf.1424. [PMID: 30773798]
  • P Kala, L Sedláková, P Škaroupková, L Kopkan, Z Vaňourková, M Táborský, A Nishiyama, S H Hwang, B D Hammock, J Sadowski, V Melenovský, J D Imig, L Červenka. Effect of angiotensin-converting enzyme blockade, alone or combined with blockade of soluble epoxide hydrolase, on the course of congestive heart failure and occurrence of renal dysfunction in Ren-2 transgenic hypertensive rats with aorto-caval fistula. Physiological research. 2018 07; 67(3):401-415. doi: 10.33549/physiolres.933757. [PMID: 29527914]
  • Paul Hermant, Damien Bosc, Catherine Piveteau, Ronan Gealageas, BaoVy Lam, Cyril Ronco, Matthieu Roignant, Hasina Tolojanahary, Ludovic Jean, Pierre-Yves Renard, Mohamed Lemdani, Marilyne Bourotte, Adrien Herledan, Corentin Bedart, Alexandre Biela, Florence Leroux, Benoit Deprez, Rebecca Deprez-Poulain. Controlling Plasma Stability of Hydroxamic Acids: A MedChem Toolbox. Journal of medicinal chemistry. 2017 11; 60(21):9067-9089. doi: 10.1021/acs.jmedchem.7b01444. [PMID: 28985084]
  • Rongzhong Huang, Yuxing Feng, Ying Wang, Xiaoxia Qin, Narayan Dhruvaraj Melgiri, Yang Sun, Xingsheng Li. Comparative Efficacy and Safety of Antihypertensive Agents for Adult Diabetic Patients with Microalbuminuric Kidney Disease: A Network Meta-Analysis. PloS one. 2017; 12(1):e0168582. doi: 10.1371/journal.pone.0168582. [PMID: 28045910]
  • Lenka Sedláková, Věra Čertíková Chábová, Šárka Doleželová, Petra Škaroupková, Libor Kopkan, Zuzana Husková, Lenka Červenková, Soňa Kikerlová, Ivana Vaněčková, Janusz Sadowski, Elzbieta Kompanowska-Jezierska, Petr Kujal, Herbert J Kramer, Luděk Červenka. Renin-angiotensin system blockade alone or combined with ETA receptor blockade: effects on the course of chronic kidney disease in 5/6 nephrectomized Ren-2 transgenic hypertensive rats. Clinical and experimental hypertension (New York, N.Y. : 1993). 2017; 39(2):183-195. doi: 10.1080/10641963.2016.1235184. [PMID: 28287881]
  • Šárka Jíchová, Libor Kopkan, Zuzana Husková, Šárka Doleželová, Jan Neckář, Petr Kujal, Zdenka Vernerová, Herbert J Kramer, Janusz Sadowski, Elzbieta Kompanowska-Jezierska, Rami N Reddy, John R Falck, John D Imig, Luděk Červenka. Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats. Journal of hypertension. 2016 10; 34(10):2008-25. doi: 10.1097/hjh.0000000000001029. [PMID: 27428043]
  • Xiaojiao Li, Chang Liu, Min Wu, Hong Zhang, Yanfu Sun, Longmei Cheng, Hong Chen, Chengjiao Liu, Lizhi Yang, Qi Zhang, Yuchen Cao, Jingkai Gu, Yanhua Ding. Pharmacokinetics, Pharmacodynamics, and Tolerability of Single and Multiple Doses of Trandolapril, an Effective Angiotensin-Converting Enzyme Inhibitor, in Healthy Chinese Subjects. European journal of drug metabolism and pharmacokinetics. 2016 Aug; 41(4):373-84. doi: 10.1007/s13318-015-0277-2. [PMID: 25864194]
  • Bülent Albayrak, Erdem Cankaya, Ramazan Cetinkaya, Serkan Cerrah, Yusuf Bilen. The effects of dual and triple combinations of trandolapril, telmisartan, and verapamil on overt proteinuria in the patients with diabetic nephropathy. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2016 May; 27(3):512-8. doi: 10.4103/1319-2442.182385. [PMID: 27215243]
  • Ahmed D Abdalrhim, Tariq S Marroush, Erin E Austin, Bernard J Gersh, Nusret Solak, Syed A Rizvi, Kent R Bailey, Iftikhar J Kullo. Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial. PloS one. 2016; 11(6):e0156965. doi: 10.1371/journal.pone.0156965. [PMID: 27284698]
  • Lubica Cibickova, Tomas Caran, Martin Dobias, Peter Ondra, Viktor Vorisek, Norbert Cibicek. Multi-drug intoxication fatality involving atorvastatin: A case report. Forensic science international. 2015 Dec; 257(?):e26-e31. doi: 10.1016/j.forsciint.2015.09.020. [PMID: 26508377]
  • Ana M Blázquez-Medela, Omar García-Sánchez, Yaremi Quirós, Victor Blanco-Gozalo, Laura Prieto-García, Sandra M Sancho-Martínez, Miguel Romero, Juan M Duarte, Francisco J López-Hernández, José M López-Novoa, Carlos Martínez-Salgado. Increased Klk9 Urinary Excretion Is Associated to Hypertension-Induced Cardiovascular Damage and Renal Alterations. Medicine. 2015 Oct; 94(41):e1617. doi: 10.1097/md.0000000000001617. [PMID: 26469898]
  • Ashwini Hariharan, Shruthi Shetty, Trupti Shirole, Aarti G Jagtap. Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration. Neurotoxicology. 2014 Dec; 45(?):139-48. doi: 10.1016/j.neuro.2014.10.004. [PMID: 25445565]
  • Jacob A Udell, David A Morrow, Petr Jarolim, Sarah Sloan, Elaine B Hoffman, Thomas F O'Donnell, Amit N Vora, Torbjørn Omland, Scott D Solomon, Marc A Pfeffer, Eugene Braunwald, Marc S Sabatine. Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease. Journal of the American College of Cardiology. 2014 Jun; 63(22):2421-8. doi: 10.1016/j.jacc.2014.03.026. [PMID: 24727254]
  • Louise Balling, Lars Kober, Morten Schou, Christian Torp-Pedersen, Finn Gustafsson. Efficacy and safety of angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and hyponatremia. Journal of cardiac failure. 2013 Nov; 19(11):725-30. doi: 10.1016/j.cardfail.2013.09.004. [PMID: 24263115]
  • Piero Ruggenenti, Esteban Porrini, Nicola Motterlini, Annalisa Perna, Aneliya Parvanova Ilieva, Ilian Petrov Iliev, Alessandro Roberto Dodesini, Roberto Trevisan, Antonio Bossi, Giuseppe Sampietro, Enrica Capitoni, Flavio Gaspari, Nadia Rubis, Bogdan Ene-Iordache, Giuseppe Remuzzi. Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes. Journal of the American Society of Nephrology : JASN. 2012 Oct; 23(10):1717-24. doi: 10.1681/asn.2012030252. [PMID: 22935482]
  • Jing Tan, Qi Hua. Correlations between serum inflammation factors and left ventricular remodeling in acute ST segment elevation myocardial infarction. Yonsei medical journal. 2012 May; 53(3):501-7. doi: 10.3349/ymj.2012.53.3.501. [PMID: 22476992]
  • Ojikumar Lukram, Mukund Zarapkar, Chandan Kumar Jha, Shivaji Parmar, Keshav S Tomar, Amit Hande. Electrospray ionization LC-MS/MS validated method for the determination of the active metabolite (R-138727) of prasugrel in human plasma and its application to a bioequivalence study. Drug testing and analysis. 2012 Feb; 4(2):158-66. doi: 10.1002/dta.264. [PMID: 21438161]
  • Marc S Sabatine, David A Morrow, James A de Lemos, Torbjorn Omland, Sarah Sloan, Petr Jarolim, Scott D Solomon, Marc A Pfeffer, Eugene Braunwald. Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease. Circulation. 2012 Jan; 125(2):233-40. doi: 10.1161/circulationaha.111.063842. [PMID: 22179538]
  • Ivana Vaněčková, Petr Kujal, Zuzana Husková, Zdeňka Vaňourková, Zdenka Vernerová, Věra Certíková Chábová, Petra Skaroupková, Herbert J Kramer, Vladimír Tesař, Luděk Červenka. Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats. Kidney & blood pressure research. 2012; 35(5):382-92. doi: 10.1159/000336823. [PMID: 22487948]
  • Morten Schou, Nana Valeur, Christian Torp-Pedersen, Finn Gustafsson, Lars Køber. Plasma sodium and mortality risk in patients with myocardial infarction and a low LVEF. European journal of clinical investigation. 2011 Nov; 41(11):1237-44. doi: 10.1111/j.1365-2362.2011.02532.x. [PMID: 21554269]
  • Michelle L O'Donoghue, Ziad Mallat, David A Morrow, Joelle Benessiano, Sarah Sloan, Torbjørn Omland, Scott D Solomon, Eugene Braunwald, Alain Tedgui, Marc S Sabatine. Prognostic utility of secretory phospholipase A(2) in patients with stable coronary artery disease. Clinical chemistry. 2011 Sep; 57(9):1311-7. doi: 10.1373/clinchem.2011.166520. [PMID: 21784767]
  • Ravi P Rao, Ak Jain, Bp Srinivasan. Dual therapy versus monotherapy of trandolapril and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats. Journal of the renin-angiotensin-aldosterone system : JRAAS. 2011 Sep; 12(3):169-75. doi: 10.1177/1470320310392097. [PMID: 21421651]
  • Alberto F Rubio-Guerra, Hilda Vargas-Robles, German Vargas-Ayala, Leticia Rodríguez-Lopez, David Castro-Serna, Bruno A Escalante-Acosta. Impact of trandolapril therapy and its combination with a calcium channel blocker on plasma adiponectin levels in patients with type 2 diabetes and hypertension. Therapeutic advances in cardiovascular disease. 2011 Aug; 5(4):193-7. doi: 10.1177/1753944711415307. [PMID: 21737486]
  • Thomas Kümler, Gunnar H Gislason, Lars Kober, Finn Gustafsson, Morten Schou, Christian Torp-Pedersen. Renal function at the time of a myocardial infarction maintains prognostic value for more than 10 years. BMC cardiovascular disorders. 2011 Jun; 11(?):37. doi: 10.1186/1471-2261-11-37. [PMID: 21708030]
  • Lorella Lambertucci, Claudia Di Serio, Sergio Castellani, Monica Torrini, Elena Lotti, Claudia Cristofari, Giulio Masotti, Niccolò Marchionni, Andrea Ungar. Trandolapril, but not verapamil nor their association, restores the physiological renal hemodynamic response to adrenergic activation in essential hypertension. Translational research : the journal of laboratory and clinical medicine. 2011 Jun; 157(6):348-56. doi: 10.1016/j.trsl.2010.12.016. [PMID: 21575919]
  • So-Young Lee, Hoe-Young Kim, Kyung Mi Park, Stephen Yon Gu Lee, Seong Geun Hong, Hyung-Jong Kim, Dong Ho Yang. MTHFR C677T polymorphism as a risk factor for vascular calcification in chronic hemodialysis patients. Journal of Korean medical science. 2011 Mar; 26(3):461-5. doi: 10.3346/jkms.2011.26.3.461. [PMID: 21394321]
  • Z Zou, F-Y Xu, L Wang, M-M An, H Zhang, X-Y Shi. Antihypertensive and renoprotective effects of trandolapril/verapamil combination: a meta-analysis of randomized controlled trials. Journal of human hypertension. 2011 Mar; 25(3):203-10. doi: 10.1038/jhh.2010.60. [PMID: 20535140]
  • V B Simonenko, I N Medvedev, O V Gamolina. [Primary hemostasis activity in patients with arterial hypertension and impaired glucose tolerance treated with trandolapril]. Klinicheskaia meditsina. 2011; 89(2):29-31. doi: NULL. [PMID: 21574438]
  • David M Charytan, Alexander M Helfand, Brian A MacDonald, Angeles Cinelli, Raghu Kalluri, Elisabeth M Zeisberg. Circulating endoglin concentration is not elevated in chronic kidney disease. PloS one. 2011; 6(8):e23718. doi: 10.1371/journal.pone.0023718. [PMID: 21886815]
  • Petr Kujal, Věra Čertíková Chábová, Zdenka Vernerová, Agnieszka Walkowska, Elzbieta Kompanowska-Jezierska, Janusz Sadowski, Zdeňka Vaňourková, Zuzana Husková, Martin Opočenský, Petra Skaroupková, Stanislava Schejbalová, Herbert J Kramer, Dan Rakušan, Jan Malý, Ivan Netuka, Ivana Vaněčková, Libor Kopkan, Luděk Cervenka. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?. Clinical and experimental pharmacology & physiology. 2010 Dec; 37(12):1159-69. doi: 10.1111/j.1440-1681.2010.05453.x. [PMID: 20880190]
  • T Dolley-Hitze, F Jouan, B Martin, S Mottier, J Edeline, O Moranne, P Le Pogamp, M-A Belaud-Rotureau, J-J Patard, N Rioux-Leclercq, C Vigneau. Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?. British journal of cancer. 2010 Nov; 103(11):1698-705. doi: 10.1038/sj.bjc.6605866. [PMID: 21102591]
  • S Reddy, A Bahl, K K Talwar. Congestive heart failure in Indians: how do we improve diagnosis & management?. The Indian journal of medical research. 2010 Nov; 132(?):549-60. doi: NULL. [PMID: 21150007]
  • Neeraj K Sethiya, Ashish Trivedi, Mayur B Patel, S H Mishra. Comparative pharmacognostical investigation on four ethanobotanicals traditionally used as Shankhpushpi in India. Journal of advanced pharmaceutical technology & research. 2010 Oct; 1(4):388-95. doi: 10.4103/0110-5558.76437. [PMID: 22247878]
  • Sofia Georgakakou, Michael Kazanis, Irene Panderi. Hydrophilic interaction liquid chromatography/positive ion electrospray ionization mass spectrometry method for the quantification of perindopril and its main metabolite in human plasma. Analytical and bioanalytical chemistry. 2010 Jul; 397(6):2161-70. doi: 10.1007/s00216-010-3551-9. [PMID: 20195579]
  • M R El-Ghobashy, H E Zaazaa. Membrane electrodes for determination of two antihypertensive drugs in pharmaceutical formulations of either single or binary mixtures and in biological fluids. Drug discoveries & therapeutics. 2010 Jun; 4(3):217-22. doi: . [PMID: 22491186]
  • Irene M van der Meer, Paolo Cravedi, Giuseppe Remuzzi. The role of renin angiotensin system inhibition in kidney repair. Fibrogenesis & tissue repair. 2010 May; 3(?):7. doi: 10.1186/1755-1536-3-7. [PMID: 20441574]
  • Nancy Houston Miller. Cardiovascular risk reduction with Renin-Angiotensin aldosterone system blockade. Nursing research and practice. 2010; 2010(?):101749. doi: 10.1155/2010/101749. [PMID: 21994809]
  • Haroon-Ur Rashid. Renoprotection, renin inhibition, and blood pressure control: the impact of aliskiren on integrated blood pressure control. Integrated blood pressure control. 2010; 3(?):133-44. doi: 10.2147/ibpc.s12407. [PMID: 21949629]
  • Xiaoyue Tan, Weichun He, Youhua Liu. Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy. Kidney international. 2009 Dec; 76(12):1248-57. doi: 10.1038/ki.2009.346. [PMID: 19759524]
  • Salvatore De Cosmo, Nicola Motterlini, Sabrina Prudente, Fabio Pellegrini, Roberto Trevisan, Antonio Bossi, Giuseppe Remuzzi, Vincenzo Trischitta, Piero Ruggenenti. Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT. Diabetes. 2009 Dec; 58(12):2920-9. doi: 10.2337/db09-0407. [PMID: 19720797]
  • Nina Vasavada, Rajiv Agarwal. Combination therapy of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease. F1000 medicine reports. 2009 Jun; 1(?):. doi: 10.3410/m1-47. [PMID: 20948734]
  • Tomas Berl. Review: renal protection by inhibition of the renin-angiotensin-aldosterone system. Journal of the renin-angiotensin-aldosterone system : JRAAS. 2009 Mar; 10(1):1-8. doi: 10.1177/1470320309102747. [PMID: 19286752]
  • Alberto F Rubio-Guerra, David Castro-Serna, Cesar I Elizalde Barrera, Luz M Ramos-Brizuela. Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors. Integrated blood pressure control. 2009; 2(?):55-62. doi: 10.2147/ibpc.s6232. [PMID: 21949615]
  • F De Leo, S Panarese, R Gallerani, L R Ceci. Angiotensin converting enzyme (ACE) inhibitory peptides: production and implementation of functional food. Current pharmaceutical design. 2009; 15(31):3622-43. doi: 10.2174/138161209789271834. [PMID: 19925416]
  • Ilka Knütter, Claudia Wollesky, Gabor Kottra, Martin G Hahn, Wiebke Fischer, Katja Zebisch, Reinhard H H Neubert, Hannelore Daniel, Matthias Brandsch. Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited. The Journal of pharmacology and experimental therapeutics. 2008 Nov; 327(2):432-41. doi: 10.1124/jpet.108.143339. [PMID: 18713951]
  • Alberto Francisco Rubio-Guerra, Hilda Vargas-Robles, German Vargas-Ayala, Leticia Rodriguez-Lopez, Bruno Alfonso Escalante-Acosta. The effect of trandolapril and its fixed-dose combination with verapamil on circulating adhesion molecules levels in hypertensive patients with type 2 diabetes. Clinical and experimental hypertension (New York, N.Y. : 1993). 2008 Oct; 30(7):682-8. doi: 10.1080/10641960802251941. [PMID: 18855271]
  • E Nakou, T D Filippatos, E N Liberopoulos, A D Tselepis, D N Kiortsis, D P Mikhailidis, M S Elisaf. Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients. Expert opinion on pharmacotherapy. 2008 Jul; 9(10):1629-39. doi: 10.1517/14656566.9.10.1629. [PMID: 18570597]
  • Monir Ahmad, Roselyn White, Junhui Tan, Bing S Huang, Frans H H Leenen. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction. Journal of cardiovascular pharmacology. 2008 Jun; 51(6):565-72. doi: 10.1097/fjc.0b013e318177090d. [PMID: 18496146]
  • Richard L Braam, Stan H M van Uum, Jacques W M Lenders, Theo Thien. Bromide as marker for drug adherence in hypertensive patients. British journal of clinical pharmacology. 2008 May; 65(5):733-6. doi: 10.1111/j.1365-2125.2007.03068.x. [PMID: 18279473]
  • Scott D Solomon, Julie Lin, Caren G Solomon, Kathleen A Jablonski, Madeline Murguia Rice, Michael Steffes, Michael Domanski, Judith Hsia, Bernard J Gersh, J Malcolm O Arnold, Jean Rouleau, Eugene Braunwald, Marc A Pfeffer. Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation. 2007 Dec; 116(23):2687-93. doi: 10.1161/circulationaha.107.723270. [PMID: 18025537]
  • C Ceconi, G Francolini, D Bastianon, G L Gitti, L Comini, R Ferrari. Differences in the effect of angiotensin-converting enzyme inhibitors on the rate of endothelial cell apoptosis: in vitro and in vivo studies. Cardiovascular drugs and therapy. 2007 Dec; 21(6):423-9. doi: 10.1007/s10557-007-6068-5. [PMID: 18004652]
  • B Liang, F H H Leenen. Prevention of salt induced hypertension and fibrosis by angiotensin converting enzyme inhibitors in Dahl S rats. British journal of pharmacology. 2007 Nov; 152(6):903-14. doi: 10.1038/sj.bjp.0707472. [PMID: 17906684]
  • D Yazici, D Gogas Yavuz, S Unsalan, A Toprak, M Yüksel, O Deyneli, H Aydin, H Tezcan, S Rollas, S Akalin. Temporal effects of low-dose ACE inhibition on endothelial function in Type 1 diabetic patients. Journal of endocrinological investigation. 2007 Oct; 30(9):726-33. doi: 10.1007/bf03350809. [PMID: 17993763]
  • Torbjørn Omland, Marc S Sabatine, Kathleen A Jablonski, Madeline Murguia Rice, Judith Hsia, Ragnhild Wergeland, Sverre Landaas, Jean L Rouleau, Michael J Domanski, Christian Hall, Marc A Pfeffer, Eugene Braunwald. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. Journal of the American College of Cardiology. 2007 Jul; 50(3):205-14. doi: 10.1016/j.jacc.2007.03.038. [PMID: 17631211]
  • Nick I Batalis, Russell A Harley, Cynthia A Schandl. Verapamil toxicity: an unusual case report and review of the literature. The American journal of forensic medicine and pathology. 2007 Jun; 28(2):137-40. doi: 10.1097/01.paf.0000257399.58935.28. [PMID: 17525564]
  • Maristela Lika Onozato, Akihiro Tojo, Naohiko Kobayashi, Atsuo Goto, Hiroaki Matsuoka, Toshiro Fujita. Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2007 May; 22(5):1314-22. doi: 10.1093/ndt/gfl780. [PMID: 17324946]
  • Ramón C Hermida, Diana E Ayala, Carlos Calvo. Optimal timing for antihypertensive dosing: focus on valsartan. Therapeutics and clinical risk management. 2007 Mar; 3(1):119-31. doi: 10.2147/tcrm.2007.3.1.119. [PMID: 18360620]
  • Richard H Tytus, Ellen D Burgess, Linda Assouline, Anita Vanjaka. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL). Clinical therapeutics. 2007 Feb; 29(2):305-15. doi: 10.1016/j.clinthera.2007.02.016. [PMID: 17472822]
  • György Jermendy, Piero Ruggenenti. Preventing microalbuminuria in patients with type 2 diabetes. Diabetes/metabolism research and reviews. 2007 Feb; 23(2):100-10. doi: 10.1002/dmrr.693. [PMID: 17094161]
  • Leszek Czupryniak, Maciej Pawłowski, Małgorzata Saryusz-Wolska, Jerzy Loba. Circadian blood pressure variation and antihypertensive medication adjustment in normoalbuminuric type 2 diabetes patients. Kidney & blood pressure research. 2007; 30(3):182-6. doi: 10.1159/000103231. [PMID: 17536225]
  • Sijie Zheng, Vijay Nath, Daniel W Coyne. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients. American journal of nephrology. 2007; 27(5):522-9. doi: 10.1159/000107490. [PMID: 17700014]
  • Ramadan A Hammoud, Christopher S Vaccari, Sameer H Nagamia, Bobby V Khan. Regulation of the renin-angiotensin system in coronary atherosclerosis: a review of the literature. Vascular health and risk management. 2007; 3(6):937-45. doi: ". [PMID: 18200812]
  • David Fitchett. Clinical trial update: focus on the ONTARGET study. Vascular health and risk management. 2007; 3(6):901-8. doi: ". [PMID: 18200809]
  • George Bakris, Mark Molitch, Ann Hewkin, Mark Kipnes, Pantelis Sarafidis, Kaffa Fakouhi, Peter Bacher, James Sowers. Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome. Diabetes care. 2006 Dec; 29(12):2592-7. doi: 10.2337/dc06-1373. [PMID: 17130190]
  • Nana Valeur, Olav Wendelboe Nielsen, John J V McMurray, Christian Torp-Pedersen, Lars Køber. Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction. European journal of heart failure. 2006 Oct; 8(6):577-84. doi: 10.1016/j.ejheart.2005.11.017. [PMID: 16678485]
  • Patricio López-Jaramillo, Lina P Pradilla, Vicente Lahera, Federico A Silva Sieger, Christian F Rueda-Clausen, Gustavo A Márquez. A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. 'ARAMIA'. Trials. 2006 Sep; 7(?):28. doi: 10.1186/1745-6215-7-28. [PMID: 16959033]
  • Wiesław Bryl, Danuta Pupek-Musialik. [The influence of ACE-inhibitor on endothelin concentration and some metabolic parameters in young hypertensives]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 2006 Aug; 21(122):174-5; discussion 176. doi: NULL. [PMID: 17144105]
  • Finlay A McAlister, Miriam Fradette, Michelle Graham, Sumit R Majumdar, William A Ghali, Randall Williams, Ross T Tsuyuki, James McMeekin, Jeremy Grimshaw, Merril L Knudtson. A randomized trial to assess the impact of opinion leader endorsed evidence summaries on the use of secondary prevention strategies in patients with coronary artery disease: the ESP-CAD trial protocol [NCT00175240]. Implementation science : IS. 2006 May; 1(?):11. doi: 10.1186/1748-5908-1-11. [PMID: 16722548]
  • A M Galløe, K Skagen, N J Christensen, S L Nielsen, E K Frandsen, P Bie, P Dalgaard, K Larsen. Dosage dependent hormonal counter regulation to combination therapy in patients with left ventricular dysfunction. Journal of clinical pharmacy and therapeutics. 2006 Apr; 31(2):139-47. doi: 10.1111/j.1365-2710.2006.00606.x. [PMID: 16635047]
  • Giuseppe Remuzzi, Manuel Macia, Piero Ruggenenti. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study. Journal of the American Society of Nephrology : JASN. 2006 Apr; 17(4 Suppl 2):S90-7. doi: 10.1681/asn.2005121324. [PMID: 16565256]
  • Erik B Friedrich, Koon K Teo, Michael Böhm. ACE inhibition in secondary prevention: are the results controversial?. Clinical research in cardiology : official journal of the German Cardiac Society. 2006 Feb; 95(2):61-7. doi: 10.1007/s00392-006-0334-6. [PMID: 16598512]
  • David G Levitt, Rik C Schoemaker. Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat. BMC clinical pharmacology. 2006 Jan; 6(?):1. doi: 10.1186/1472-6904-6-1. [PMID: 16398929]
  • Ramakrishna V S Nirogi, Vishwottam N Kandikere, Wishu Shrivastava, Koteshwara Mudigonda. Quantification of trandolapril and its metabolite trandolaprilat in human plasma by liquid chromatography/tandem mass spectrometry using solid-phase extraction. Rapid communications in mass spectrometry : RCM. 2006; 20(24):3709-16. doi: 10.1002/rcm.2794. [PMID: 17117442]
  • Kailash Prasad. C-reactive protein (CRP)-lowering agents. Cardiovascular drug reviews. 2006; 24(1):33-50. doi: 10.1111/j.1527-3466.2006.00033.x. [PMID: 16939632]
  • Junko Shoda, Yoshihiko Kanno, Hiromichi Suzuki. A five-year comparison of the renal protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with non-diabetic nephropathy. Internal medicine (Tokyo, Japan). 2006; 45(4):193-8. doi: 10.2169/internalmedicine.45.1515. [PMID: 16543688]
  • R M Golding, L G F Giles. A method for extracting muscle information from serum creatine kinase measurements--its potential value in the monitoring and management of inflammatory muscle disease. Medical hypotheses. 2006; 66(3):476-85. doi: 10.1016/j.mehy.2005.09.042. [PMID: 16298493]
  • Mensura Ascerić, Nedzad Mulabegović, Sabina Nuhbegović, Alma Nadarević, Muamera Mujcinagić-Vrabac. Antihypertensive treatment in patients with end-stage renal disease. Bosnian journal of basic medical sciences. 2005 Nov; 5(4):22-5. doi: 10.17305/bjbms.2005.3225. [PMID: 16351593]
  • Ramón C Hermida, Diana E Ayala, Carlos Calvo. Administration-time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure. Current opinion in nephrology and hypertension. 2005 Sep; 14(5):453-9. doi: 10.1097/01.mnh.0000174144.07174.74. [PMID: 16046904]
  • Gunter Wolf. [The renin-angiotensin-aldosterone system -- more complex as previously thought]. Medizinische Klinik (Munich, Germany : 1983). 2005 Aug; 100(8):471-7. doi: 10.1007/s00063-005-1071-8. [PMID: 16096728]
  • William J Elliott. Cardiovascular events in hypertension trials of Angiotensin-converting enzyme inhibitors. Journal of clinical hypertension (Greenwich, Conn.). 2005 Aug; 7(8 Suppl 2):2-4. doi: 10.1111/j.1524-6175.2005.04567.x. [PMID: 16106130]
  • Atsuhiro Ichihara, Matsuhiko Hayashi, Yuki Kaneshiro, Tomoko Takemitsu, Koichiro Homma, Yoshihiko Kanno, Mamoru Yoshizawa, Tomohiro Furukawa, Tsuneo Takenaka, Takao Saruta. Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2005 May; 45(5):866-74. doi: 10.1053/j.ajkd.2005.02.022. [PMID: 15861352]
  • Wiesław Bryl, Anna Miczke, Paweł Bogdański, Magdalena Kujawska-Luczak, Maciej Cymerys, Danuta Pupek-Musialik, Olga Trojnarska. [Assessment of blood pressure and endothelin-1 plasma concentration in young, hypertensive patients after treatment with angiotensin converting enzyme inhibitor]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 2005 May; 18(107):524-6. doi: NULL. [PMID: 16161947]
  • Alexander Logan. BENEDICT in the treatment of hypertension. Current hypertension reports. 2005 Apr; 7(2):121-3. doi: 10.1007/s11906-005-0085-1. [PMID: 15748536]
  • Y Kanno, H Okada, Y Yamaji, Y Nakazato, H Suzuki. Angiotensin-converting-enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation. QJM : monthly journal of the Association of Physicians. 2005 Mar; 98(3):199-203. doi: 10.1093/qjmed/hci036. [PMID: 15728401]
  • Sabine C Wolf, Gabriele Sauter, Teut Risler, Bernhard R Brehm. Effects of combined endothelin and angiotensin II antagonism on growth factor-induced proliferation of vascular smooth muscle cells isolated from uremic rats. Renal failure. 2005; 27(4):465-74. doi: NULL. [PMID: 16060137]
  • Cipy Hofman, Efraim Gabai, Edna Peleg, Klaus Munter, Talma Rosenthal. Endothelin A antagonist LU-135252 and trandolapril in the treatment of the Cohen-Rosenthal diabetic hypertensive rat. Blood pressure. 2005; 14(2):114-9. doi: 10.1080/08037050510008913. [PMID: 16036489]
  • Atsuhisa Sato, Koichi Hayashi, Takao Saruta. Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease. American journal of hypertension. 2005 Jan; 18(1):44-9. doi: 10.1016/j.amjhyper.2004.06.029. [PMID: 15691616]
  • Marta Prieto, Ana Rodríguez-Peña, Miguel Arévalo, Juan V Rivas, Annette Düwel, Nélida Eleno, Rafael J Sánchez, Ana I Morales, José M López-Novoa, Fernando Pérez-Barriocanal. Effect of the long-term treatment with trandolapril on endoglin expression in rats with experimental renal fibrosis induced by renal mass reduction. Kidney & blood pressure research. 2005; 28(1):32-40. doi: 10.1159/000081439. [PMID: 15475654]
  • Ulrich P Jorde, Timothy J Vittorio, Clarito A Dimayuga, Shunichi Homma, Adel Rizkala, Thierry H Le Jemtel, Stuart D Katz. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure. The American journal of cardiology. 2004 Dec; 94(12):1501-5. doi: 10.1016/j.amjcard.2004.08.027. [PMID: 15589004]
  • Eugene Braunwald, Michael J Domanski, Sarah E Fowler, Nancy L Geller, Bernard J Gersh, Judith Hsia, Marc A Pfeffer, Madeline M Rice, Yves D Rosenberg, Jean L Rouleau. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. The New England journal of medicine. 2004 Nov; 351(20):2058-68. doi: 10.1056/nejmoa042739. [PMID: 15531767]
  • Charlotte Kragelund, Ole Snorgaard, Lars Køber, Bruno Bengtsson, Michael Ottesen, Søren Højberg, Claus Olesen, Jens-Jørgen Kjaergaard, Jan Carlsen, Christian Torp-Petersen. Hyperinsulinaemia is associated with increased long-term mortality following acute myocardial infarction in non-diabetic patients. European heart journal. 2004 Nov; 25(21):1891-7. doi: 10.1016/j.ehj.2004.07.033. [PMID: 15522467]
  • Naoyuki Nakao, Hachiro Seno, Hirotake Kasuga, Takanobu Toriyama, Hirohisa Kawahara, Masafumi Fukagawa. Effects of combination treatment with losartan and trandolapril on office and ambulatory blood pressures in non-diabetic renal disease: a COOPERATE-ABP substudy. American journal of nephrology. 2004 Sep; 24(5):543-8. doi: 10.1159/000081953. [PMID: 15528874]
  • Lawrence G Hunsicker. Emerging trends for prevention and treatment of diabetic nephropathy: blockade of the RAAS and BP control. Journal of managed care pharmacy : JMCP. 2004 Sep; 10(5 Suppl A):S12-7. doi: 10.18553/jmcp.2004.10.s5-a.s12. [PMID: 15369420]
  • Alberto Francisco Rubio-Guerra, Adalberto Arceo-Navarro, German Vargas-Ayala, Leticia Rodriguez-Lopez, Jose Juan Lozano-Nuevo, Carlos Treviño Gomez-Harper. The effect of trandolapril and its fixed-dose combination with verapamil on proteinuria in normotensive adults with type 2 diabetes. Diabetes care. 2004 Jul; 27(7):1688-91. doi: 10.2337/diacare.27.7.1688. [PMID: 15220247]
  • Yoshihiro Takamitsu. [Therapeutic strategy for patients with stable-stage chronic kidney failure]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine. 2004 Mar; 93(3):477-82. doi: 10.2169/naika.93.477. [PMID: 15052806]
  • Tomoaki Yamaguchi, Takashi Ida, Masazumi Hiraga, Kazuhiko Oishi, Masaatsu K Uchida, Hirotoshi Echizen. [Effects of angiotensin II receptor blockers, angiotensin converting enzyme inhibitors, 3-hydroxy-3-methyl glutaryl (HMG) CoA reductase inhibitors, amlodipine and epalrestat on cultured basilar artery smooth muscle cell proliferation]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 2004 Mar; 124(3):159-63. doi: 10.1248/yakushi.124.159. [PMID: 15049134]